Drugs

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Drugs

Ipilimumab and Nivolumab for patients with unresected advanced Hepatocellular Carcinoma – ESMO

Photo from ESMO/LinkedIn

Jul 5, 2024, 02:30

Ipilimumab and Nivolumab for patients with unresected advanced Hepatocellular Carcinoma – ESMO

ESMO shared on LinkedIn:

“Benefits reported for the combination of ipilimumab and nivolumab further expand alternative therapeutic options for patients with unresected advanced Hepatocellular Carcinoma.
Read the opinion piece by Angela Lamarca on ESMO Daily Reporter.”

Source: ESMO/LinkedIn

Angela Lamarca cancer ESMO ESMO Daily Reporter hepatocellular carcinoma ipilimumab nivolumab OncoDaily Oncology

Aug 16, 2024, 20:40

Sachin H. Jain: SCAN was recognized this year as one of the Top Diversity Leader Organization

Aug 16, 2024, 20:26

Arunah Chandran: Empowering Grassroots for Cancer Awareness in Udaipur, Rajasthan

Aug 16, 2024, 20:23

Incredible $1.7m for childhood cancer research - Children's Cancer Institute

Aug 16, 2024, 20:19

Carmen Uscatu is calling all lawyers to join Dăruiește Viață's mission

Aug 16, 2024, 20:12

The EU Cancer Plan and the EU Research Mission on Cancer laid strong foundations for better access to quality Cancer Care - European Cancer Organisation

Aug 16, 2024, 20:05

Focused ultrasound and cancer immunotherapy to develop safer and more efficient combination therapies - Cancer Research Institute

Aug 16, 2024, 20:00

UICC reiterates its call for stricter regulations around all forms of tobacco products, including vapes

Aug 16, 2024, 19:53

Karen Knudsen: Home away from home for patients and caregivers

Aug 16, 2024, 19:45

Jarushka Naidoo: SYK signature predicts irAEs from adjuv ICI in melanoma

Aug 16, 2024, 19:37

Shearwood McClelland III: Financial Toxicity associated with achieving PFS based on the INDIGO trial

Aug 16, 2024, 19:33

Mark Lewis: Inigo Montoya would be proud

Aug 16, 2024, 19:25

Toufic Kachaamy: The fusion of precision medicine, AI, and advanced cancer screening in cancer care